The company is commercialising novel Car T-cell therapy developed in New Zealand for cancer and other patients.
Board members also announced for new NZ Institute for Advanced Technology.
Global payments provider is on the charm offensive in New Zealand, releasing a report calling on industry and Government to work together.
Long-time backer Icehouse Ventures also increases its stake in the Wellington accounting fintech.
The Booster Innovation Fund signs a strategic partnership with Auckland UniServices.
The venture capital firm wants to invest more into globally successful Kiwis.
The projects include a Whangārei pilot plant, which had been operating without consent, NBR investigations reveal.
A review of the Government’s early-stage investment agency’s Aspire Fund could see it writing the first cheque for startups.
New CEO says he’ll have a lot more to say about his vision next year.
The company’s planning a commercial launch of its methane-inhibiting bolus for ruminant animals early next year in New Zealand and Australia.